Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,483 | 221 | 98.0% |
| Education | $89.85 | 2 | 2.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Neurocrine Biosciences, Inc. | $744.77 | 31 | $0 (2024) |
| ABBVIE INC. | $713.11 | 46 | $0 (2024) |
| Alkermes, Inc. | $582.23 | 34 | $0 (2024) |
| ITI, Inc. | $492.08 | 31 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $392.57 | 18 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $333.82 | 15 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $316.89 | 16 | $0 (2024) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $223.16 | 2 | $0 (2023) |
| ACADIA Pharmaceuticals Inc | $205.89 | 4 | $0 (2024) |
| Lundbeck LLC | $177.21 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,055 | 53 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) ($316.89) |
| 2023 | $1,315 | 42 | Alkermes, Inc. ($239.01) |
| 2022 | $796.74 | 52 | ITI, Inc. ($236.08) |
| 2021 | $1,406 | 76 | Neurocrine Biosciences, Inc. ($399.57) |
All Payment Transactions
223 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $67.89 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/11/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $20.02 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 12/04/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $23.94 | General |
| Category: PSYCHIATRY | ||||||
| 12/02/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $24.07 | General |
| Category: CNS | ||||||
| 11/22/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: Neuropsychiatry | ||||||
| 11/21/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $27.68 | General |
| Category: PSYCHIATRY | ||||||
| 11/07/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $32.83 | General |
| 11/07/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $15.33 | General |
| Category: PSYCHIATRY | ||||||
| 10/31/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $20.69 | General |
| Category: Neuroscience | ||||||
| 10/25/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $23.19 | General |
| Category: CNS | ||||||
| 10/24/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: Neuroscience | ||||||
| 10/23/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $30.34 | General |
| Category: PSYCHIATRY | ||||||
| 10/13/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $21.47 | General |
| Category: Neuropsychiatry | ||||||
| 10/07/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: PSYCHIATRY | ||||||
| 09/26/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $11.15 | General |
| Category: CNS | ||||||
| 09/13/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: PSYCHIATRY | ||||||
| 09/12/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: PSYCHIATRY | ||||||
| 08/29/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $23.96 | General |
| Category: Neuroscience | ||||||
| 08/14/2024 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: CNS | ||||||
| 08/01/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $28.08 | General |
| Category: PSYCHIATRY | ||||||
| 07/24/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $12.84 | General |
| Category: PSYCHIATRY | ||||||
| 07/24/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $1.64 | General |
| Category: PSYCHIATRY | ||||||
| 07/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: NEUROSCIENCE | ||||||
| 07/11/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $29.56 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 07/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 276 | 614 | $81,736 | $36,999 |
| 2022 | 6 | 320 | 625 | $87,219 | $36,209 |
| 2021 | 6 | 441 | 943 | $124,795 | $53,317 |
| 2020 | 7 | 348 | 627 | $88,689 | $38,237 |
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 74 | 343 | $36,983 | $17,613 | 47.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 56 | 56 | $16,933 | $6,322 | 37.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 44 | 64 | $10,542 | $4,957 | 47.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 50 | 54 | $8,622 | $4,019 | 46.6% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 40 | 77 | $4,551 | $2,482 | 54.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 12 | 20 | $4,105 | $1,607 | 39.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 69 | 264 | $28,332 | $11,903 | 42.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 63 | 111 | $18,273 | $7,339 | 40.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 54 | 55 | $16,887 | $6,827 | 40.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 70 | 80 | $12,786 | $5,486 | 42.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 22 | 29 | $5,918 | $2,547 | 43.0% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 42 | 86 | $5,023 | $2,108 | 42.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 102 | 445 | $47,705 | $20,853 | 43.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 80 | 80 | $24,178 | $10,272 | 42.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 101 | 124 | $19,761 | $8,468 | 42.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 60 | 88 | $14,514 | $5,770 | 39.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 39 | 46 | $9,352 | $3,982 | 42.6% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 59 | 160 | $9,285 | $3,972 | 42.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 93 | 252 | $27,138 | $12,181 | 44.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 51 | 51 | $15,413 | $6,790 | 44.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 68 | 78 | $12,417 | $5,506 | 44.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 48 | 75 | $12,161 | $5,226 | 43.0% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 34 | 41 | $8,332 | $3,728 | 44.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 13 | 50 | $8,503 | $2,699 | 31.7% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 41 | 80 | $4,725 | $2,107 | 44.6% |
About Philippe Petrus, PA-C
Philippe Petrus, PA-C is a Physician Assistant healthcare provider based in El Paso, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/24/2007. The National Provider Identifier (NPI) number assigned to this provider is 1639398035.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Philippe Petrus, PA-C has received a total of $4,573 in payments from pharmaceutical and medical device companies, with $1,055 received in 2024. These payments were reported across 223 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($4,483).
As a Medicare-enrolled provider, Petrus has provided services to 1,385 Medicare beneficiaries, totaling 2,809 services with total Medicare billing of $164,762. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Other Specialties Medical
- Location El Paso, TX
- Active Since 04/24/2007
- Last Updated 08/08/2025
- Taxonomy Code 363A00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1639398035
Products in Payments
- CAPLYTA (Drug) $808.97
- INGREZZA (Drug) $744.77
- VRAYLAR (Drug) $713.11
- ARISTADA (Drug) $548.46
- REXULTI (Drug) $368.44
- INVEGA SUSTENNA (Drug) $353.69
- NUPLAZID (Drug) $205.89
- ABILIFY MAINTENA (Drug) $121.96
- TRINTELLIX (Drug) $107.74
- AUSTEDO (Drug) $56.92
- Austedo XR (Drug) $46.17
- SPRAVATO (Drug) $38.88
- Azstarys (Drug) $34.57
- IGALMI (Drug) $24.90
- JORNAY PM (Drug) $20.02
- Dyanavel XR (Drug) $19.90
- VIVITROL (Drug) $18.92
- AZSTARYS (Drug) $17.82
- Auvelity (Drug) $15.45
- Vivitrol (Drug) $14.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in El Paso
Javier Almeida, P.a.-C, P.A.-C
Physician Assistant — Payments: $19,908
Myrna Bejar, Pa, PA
Physician Assistant — Payments: $10,964
Elvis Jacome, Pa-C, PA-C
Physician Assistant — Payments: $7,894
Damaris Rosado, Pa-C, PA-C
Physician Assistant — Payments: $6,826
Ryan Rodriguez, Pa-C, Atc, PA-C, ATC
Physician Assistant — Payments: $5,401
Clyde Morron, Pa, PA
Physician Assistant — Payments: $5,288